Point72 Asset Management »

ADC Therapeutics SA shares owned by Point72 Asset Management

Quarter-by-quarter ownership of ADC Therapeutics SA (ADCT) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in ADC Therapeutics SA

Tip: Access up to 7 years of quarterly data

All positions including ADC Therapeutics SA held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ADC Therapeutics SA by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $33M 8.1M 4.00
2025-06-30 $21M 7.8M 2.68
2022-12-31 $2.7M 705k 3.84

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Arista Networks Com Shs (ANET)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Amazon (AMZN)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Biogen Idec (BIIB)
Meta Platforms Cl A (META)
Teradyne (TER)
Advanced Micro Devices (AMD)
Asml Holding N V N Y Registry Shs (ASML)
Broadcom (AVGO)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Airbnb Com Cl A (ABNB)

View all positions for Point72 Asset Management

Top funds holding ADC Therapeutics SA

Redmile Group
Point72 Asset Management
Prosight Management
OrbiMed Advisors
BlackRock
Morgan Stanley
Nantahala Capital Management
Goldman Sachs Group
TCG Crossover Management
Lynx1 Capital Management
State Street Corporation
Platinum Investment Mangement
Geode Capital Management
Citadel Advisors
Blue Owl Capital Holdings

View all funds holding ADC Therapeutics SA